Abstract
Transurethral resection is the standard treatment for superficial bladder cancer and benign prostatic enlargement (BPE). Utilization of a novel transurethral resection protocol involving saline (TURis) protects the obturator nerve from problematic reflex. We evaluated our TURis experience with superficial bladder cancer and BPE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.